艾美捷科技代理Medix Biochemica品牌。

Medix Biochemica是重要的体外诊断原材料供应商，生产和供应高质量的抗体、抗原和其他关键的IVD原材料，涵盖免疫测定、临床化学和分子诊断等细分市场。Medix Biochemica拥有5000多种产品，可提供超过95%的最常见试剂，用于检测开发、生产和验证。Medix Biochemica提供高质量的单克隆抗体，也可以提供定制OEM服务，让抗体生产变得轻松。该工艺包括通过细胞系驯化、支原体检测、生产优化和验证进行评估和优化。

Medix Biochemica产品包括：

（1）抗体/抗原/酶：包含5000多种产品，涵盖300多种指标；

（2）MedixMDx：分子生物学应用原料；

（3）生物样本和生物材料。

英国IDS(Immunodiagnostic Systems Limited)公司成立于1977年。主要擅长于骨代谢系列酶免诊断试剂。现已成为体外诊断试剂行业全球公认的创新者和市场佼佼者。特别在骨疾病和钙吸收功能紊乱（骨质疏松、骨软化、变形性骨炎）辅助诊断和治疗疗效监测工具开发、实际应用方面及上述骨异常基本原理机制研究方面，英国IDS公司以经验丰富而闻名于全球。

IDS provides laboratories worldwide with clinical and research solutions in the field of specialty endocrinology. We aim to enhance laboratory efficiency, improve diagnostic accuracy and enrich diagnostic outcomes for patients.

We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.

Immunodiagnostic Systems的主要产品包括：

IDS-iSYS Multi-Discipline Automated System

Bone Metabolism

Calcium Metabolism

Hypertension

CKD-MBD

Cartilage Markers

Growth

Fertility

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com